Rooted Owl taps Dr. Barbara Royal to lead nutrition strategy
Bottom line
Rooted Owl has named Barbara Royal, DVM, CVA, CVNN, CIVTN, FACVBM, as senior veterinary advisor and head of nutrition, giving the New York-based pet supplement company a higher-profile clinical leader as it expands its science and product pipeline. In the role, Royal is expected to guide product formulation, clinical study design, veterinary education, and outreach to retail and clinical partners. The company said the appointment comes as it advances two active clinical studies, maintains a 14-SKU portfolio, and prepares to launch a 12-SKU feline line in the coming months. (globenewswire.com)
Why it matters: For veterinary professionals, the move signals that Rooted Owl is trying to strengthen its credibility in a crowded supplement category by leaning harder into formulation oversight, clinical study design, and practitioner education. Royal brings a long-standing profile in integrative veterinary medicine and nutrition, including leadership roles with Animal Diet Formulator and the College of Integrative Veterinary Therapies, which could help the company make a more direct case to clinics evaluating evidence, ingredient transparency, and supplement quality standards. (globenewswire.com)
What to watch: Watch for details on the feline launch, topline data from Rooted Owl’s active studies in 2026 and 2027, and whether the company translates this appointment into stronger veterinary-channel adoption. (globenewswire.com)
Rooted Owl is bringing a better-known veterinary voice into its leadership ranks, appointing Barbara Royal, DVM, as senior veterinary advisor and head of nutrition. The hire gives the New York-based supplement company added clinical visibility at a time when it says it is running two active studies, expanding distribution, and preparing a feline-specific product launch. (globenewswire.com)
The timing matters because Rooted Owl is still an emerging brand, but one that has been positioning itself around science-backed, condition-specific supplements rather than broader wellness marketing. Company materials say its products are veterinarian formulated, manufactured in GMP-compliant facilities, third-party tested, and backed by Certificates of Analysis available to veterinarians, retailers, and pet parents. An NASC listing also emphasizes standardized extracts, clean labeling, and batch-to-batch consistency, all points that matter in a supplement market where veterinary confidence often hinges on manufacturing discipline as much as ingredient choice. (rootedowl.com)
According to the company’s September 29, 2026 announcement, Royal will oversee product formulation, clinical study design, education for veterinary professionals, and engagement with prospective retail and clinical partners. Rooted Owl also used the announcement to highlight its broader growth story: 14 SKUs currently on the market, distribution through Amazon, Chewy, Petco Mexico, independent stores, and chains, plus a 12-SKU feline line in final formulation. That cat-focused line is expected to include targeted products such as cardio support and kidney support. (globenewswire.com)
Rooted Owl is also leaning on Royal’s credentials to reinforce its evidence-based positioning. The company described her as a pioneer in integrative veterinary nutrition, and her current roles include owner and CEO of Animal Diet Formulator and the College of Integrative Veterinary Therapies. Her broader public profile includes work in integrative practice, education, and advisory roles across companion animal nutrition and wellness. (globenewswire.com)
Industry reaction so far has largely echoed the company’s message rather than challenged it. Rooted Owl’s LinkedIn announcement framed Royal’s appointment as aligned with the brand’s focus on “scientific rigor, ingredient transparency, and thoughtful formulations,” while trade coverage in Pet Age and other pickups has emphasized the same themes: clinical credibility, nutrition leadership, and the pending feline expansion. I did not find independent third-party expert criticism or outside analyst commentary on the appointment itself, which is common for executive and advisory moves at smaller pet health brands. (linkedin.com)
Why it matters: For veterinarians, the bigger story isn’t just a personnel change. It’s that supplement companies increasingly know they need stronger clinical narratives, clearer quality controls, and more veterinary-facing education if they want to move beyond direct-to-consumer interest and into routine clinical recommendation. Rooted Owl’s emphasis on active studies, NASC standards, third-party testing, and a named nutrition lead suggests it’s trying to meet that bar. Whether that translates into meaningful clinical trust will depend less on branding and more on published data, formulation transparency, and how well products hold up in everyday case management. (globenewswire.com)
The feline angle may be especially relevant. Cat supplements remain a more selective and compliance-sensitive segment than dog products, and targeted formulations for areas like kidney and cardiovascular support could draw interest if the company can pair palatability, administration ease, and evidence with realistic clinical use cases. Royal’s background in integrative nutrition may help Rooted Owl shape that message for clinics that are open to adjunctive products, but still cautious about overpromised claims. (globenewswire.com)
What to watch: The next markers will be concrete ones: launch timing and retail placement for the feline line, whether Rooted Owl releases fuller study details or peer-reviewed data from its active trials in 2026 and 2027, and whether Royal becomes a visible educator for the brand in CE, clinic outreach, or veterinary-channel partnerships. (globenewswire.com)